Urologix, Inc. (ULGX)

Urologix Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Mar 31, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010
Net Income	-4.67	-7.61	-4.29	-4.7	-3.73	-2.17
Depreciation & Amortization	0.5	0.59	0.67	0.7	0.57	0.79
Loss (Gain) From Sale of Assets	0.01	0.01	0.01	0.02	0.01	0
Asset Writedown & Restructuring Costs	3.04	3.04	0.43	-	-	-
Stock-Based Compensation	0.1	0.21	0.26	0.36	0.37	0.44
Provision & Write-off of Bad Debts	0.04	0.01	-0.02	-0.03	-0.05	0.05
Other Operating Activities	0.46	1.07	-0.11	0.51	-	-
Change in Accounts Receivable	0.37	0.62	0.02	-0.74	0.07	0.08
Change in Inventory	0.03	0.27	-0.63	0.13	0.24	-0.39
Change in Accounts Payable	-0.31	0.26	1.76	2.64	0.31	-0.03
Change in Other Net Operating Assets	0.18	0.01	-0.07	0.41	-0.15	-0.03
Operating Cash Flow	-0.26	-1.53	-1.96	-0.71	-2.37	-1.26
Capital Expenditures	-0.01	-0.03	-0.08	-0.06	-0.27	-0.08
Cash Acquisitions	-	-	-1.37	-0.5	-	-
Sale (Purchase) of Intangibles	-0.02	-0.01	-0.03	-0.01	-0	-0
Investing Cash Flow	-0.06	-0.04	-1.48	-0.57	-0.28	-0.09
Issuance of Common Stock	-	-	3.83	0.12	0	0.01
Financing Cash Flow	-	-	3.83	0.12	0	0.01
Net Cash Flow	-0.32	-1.57	0.39	-1.16	-2.64	-1.33
Free Cash Flow	-0.28	-1.56	-2.04	-0.77	-2.64	-1.34
Free Cash Flow Margin	-2.29%	-11.15%	-12.36%	-4.52%	-21.02%	-9.04%
Free Cash Flow Per Share	-0.01	-0.07	-0.10	-0.05	-0.18	-0.09
Cash Income Tax Paid	0.01	0.03	0.02	0.01	0.02	0.01
Levered Free Cash Flow	0.73	-0.38	-6.8	2.67	-1.56	-0.35
Unlevered Free Cash Flow	1.21	0.05	-6.45	2.97	-1.56	-0.35
Change in Net Working Capital	-1.19	-1.78	4.61	-4.4	-0.04	0.09

Updated May 14, 2015. Source: S&P Global Market Intelligence. Standard template. Financial Sources.